Kezar Life Sciences (KZR) Misses Q2 EPS by 187c
Tweet
Share
E-mailGet Alerts KZR Hot Sheet
Join SI Premium – FREE
Kezar Life Sciences (NASDAQ: KZR) reported Q2 EPS of ($1.87).
For earnings history and earnings-related data on Kezar Life Sciences (KZR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- Stifel Canada Starts BlackBerry (BB) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
